Clinical trial
Combination Chemotherapy and Thalidomide in Treating Younger Patients Undergoing…
NCT00276705 · Children's Cancer and Leukaemia Group, Other · Unknown status
Key facts
| NCT number | NCT00276705 |
|---|---|
| Title | Combination Chemotherapy and Thalidomide in Treating Younger Patients Undergoing Surgery For Newly Diagnosed Liver Cancer |
| Official title | Hepatocellular Carcinoma Family of Tumours In Children / Adolescents and Young Adults |
| Lead sponsor | Children's Cancer and Leukaemia Group, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Liver Cancer |
| Intervention type | Drug, Procedure |
| Interventions | cisplatin, cyclophosphamide, doxorubicin hydrochloride, thalidomide, adjuvant therapy, conventional surgery, neoadjuvant therapy |
| Enrollment | 47 |
| Start date | Jun 1, 2005 |
| Primary completion | Apr 1, 2009 |
| First posted | Jan 13, 2006 |
| Last update posted | Sep 17, 2013 |
| Countries | Ireland, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: